The second day of the CX Venous Workshop was held yesterday on the Upper Level of the Gallery, rounding off a busy week in which more than 950 people visited over the two days—a new record for the Workshop. Once again the educational stations, of which there were more than 30, were packed with delegates looking forward to one-on-one time with the distinguished Charing Cross Symposium faculty.
As was the case on Wednesday, the “Endovenous Ablation Village” was running, showcasing all available techniques to ablate truncal veins, along with practical training sessions teaching ultrasound-guided cannulation, catheter positioning and tumescent anaesthesia.
While the first day of the workshop focused largely on varicose veins and superficial venous issues, yesterday went deeper into the vein by examining acute deep vein thrombosis, intravascular ultrasound and deep venous stenting. Every station saw a significant amount of traffic, with delegates showing a keen interest in the intravascular ultrasound and deep vein thrombosis stations.
Ian Franklin, one of the course directors, said “Today we have had a big change of interest to deep venous—treatments of deep vein thrombosis, deep vein stenting, intravascular ultrasound, pelvic vein embolisation and so on—and it is packed. There is not a single empty training station, everyone has good interest and it is sustained. We deliberately have this flexible format so people can come and go—if they find they have a gap in the programme they can come and join us and make sure their time is used profitably.”
As the workshop drew to a close for another year, thoughts turned towards 2016. “Every year we change the event and it has never been the same as it was before, so next year will definitely be different,” said Franklin. “One thing I would consider is bringing in recorded live cases of all the new techniques we are showcasing to complement the hands-on demonstrations, using screens and some commentaries.”
With the workshop in its seventh year, there is always the opportunity to resurrect popular aspects of previous years’ Workshops. For example, Franklin suggested, “I would also like to bring back interactive discussion of complicated and difficult cases. That was always very popular, especially when you had a series of well-known experts all discussing how best to handle a case. Quite often we are showcasing different techniques and then once you have learnt that technique there comes the discussion of when to use it, so I think those case-based discussions complement the learning too.”
Day 2 offered stations covering: thermal (laser), thermal (radiofrequency ablation), non-thermal, practical training stations, valves, vascular ultrasound training simulator, venous malformations, pelvic venous imaging, pelvic vein embolisation, acute deep vein thrombosis, caval filters, follow-up protocols, air plethysmography, intravenous ultrasound and deep vein stenting.
Alma Lasers was exhibiting its VascuLife minimally invasive varicose vein laser treatment with robotic pullback. Having received CE mark and FDA approval recently, the VascuLife station had plenty of visitors looking to learn about the robotic pullback capability, which standardises pullback rate safely and allows a surgeon to focus on other tasks while pullback is completed. Shira Doron, marketing director at Alma Lasers, believes that the CX Venous Workshop gave companies and physicians a chance to interact and share information in an informal and purely scientific setting. She said, “Physicians view this as their professional platform as opposed to booths, which may feel like more of a marketing platform. They come here and it is all about the device and what it can do. You do not need to see movies or brochures—it is all about the technology.”
The new ArtVentive EOS device also was highlighted yesterday. Krzysztof Pyra (Lublin, Poland) spoke his experience with the EOS device treating ovarian veins for pelvic congestion syndrome. In addition, treatment of spermatic vein varicoceles were also presented. Pyra discussed his approach to diagnosing and treating pelvic vein incompetence. According to Pyra, of particular note was the immediacy of occlusion with the EOS device and shorter procedure times. Pyra uses a combination of EOS and sclerosant to occlude the pelvic veins.